. . "5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine"@en . . . "5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine"@en . "Side effects include agitation, coma, confusion, convulsions, dilated pupils, disturbed concentration, drowsiness, hallucinations, high fever, irregular heart rate, low body temperature, muscle rigidity, overactive reflexes, severely low blood pressure, stupor, vomiting"@en . "739-71-9"@en . "Trimipramine's mechanism of action differs from other tricyclic antidepressants. Trimipramine acts by decreasing the reuptake of norepinephrine and serotonin (5-HT)."@en . . "Sapilent"@en . "Trimipramine"@en . . . . . . . . . . . . . . . . . . . . "Trimipramina"@en . . . "RP-7162"@en . . . . . "Humans and other mammals"@en . . . "approved"@en . . "Trimeproprimine"@en . . . . "10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine"@en . "Trimipraminum"@en . "For the treatment of depression and depression accompanied by anxiety, agitation or sleep disturbance"@en . " "@en . . . . "Trimeprimina"@en . "Rapid absorption"@en . . . . . "Trimipramine"@en . . . . . . " "@en . . . . "11-18 hrs"@en . "Trimeprimine"@en . . . . "beta-Methylimipramine"@en . . "93%-96% (to plasma proteins)"@en . . . . . . . . "Tricyclic antidepressant similar to imipramine, but with more antihistaminic and sedative properties. [PubChem]"@en . .